Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -251.73x is 51% above its 2-year average of -517.38x, near the high end of its 2-year range (-1164.35x–-136.07x).
As of the fiscal period ended Monday, May 31, 2010. 29.83% below its 12-month average of -193.90x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2010 (2010-05-31): -251.73x.
INTEREST COVERAGE RATIO
-251.73x
INTEREST COVERAGE RATIO AVG TTM
-193.90x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-29.83%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-5851.00%
vs the sector median at left
Edesa Biotech, Inc.
Market Cap
$37.81M
Interest Coverage Ratio
-251.73x
TTM Avg
-193.90x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.60M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
Market Cap
$38.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.38M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$37.14M
Interest Coverage Ratio
-0.75x
TTM Avg
0.33x
3Y Avg
0.47x
5Y Avg
0.65x
Market Cap
$35.58M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.32M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.82M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$40.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.81M | -251.73x | -193.90x | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.60M | -0.13x | 0.53x | 0.64x | 0.43x |
| Incannex Healthcare Limited (IXHL)vs › | $38.82M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.38M | -87.92x | 13.24x | 16.68x | 16.68x |
| Accuray Incorporated (ARAY)vs › | $37.14M | -0.75x | 0.33x | 0.47x | 0.65x |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.58M | -735.69x | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | -33.29x | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $35.82M | 47.58x | 47.58x | 47.58x | 47.58x |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | N/A | N/A | N/A | N/A |
Interest Coverage
-251.7x
Debt/Equity
0.00
Current Ratio
2.76
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2010-05-31 | -251.73x |
| 2009-10-31 | -136.07x |
| 2008-10-31 | -1164.35x |
